Nivalin 10mg/ml solution for injection solution for injection

국가: 아르메니아

언어: 영어

출처: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

제품 특성 요약 제품 특성 요약 (SPC)
11-09-2017

유효 성분:

galantamine (galantamine hydrobromide)

제공처:

Sopharma JSC

ATC 코드:

N06DA04

INN (International Name):

galantamine (galantamine hydrobromide)

복용량:

10mg/ml

약제 형태:

solution for injection

패키지 단위:

(10) ampoules 1ml

처방전 유형:

Prescription

승인 상태:

Registered

승인 날짜:

2017-09-05

제품 특성 요약

                                KPATI{A.{
XAPAKTEPHCTI{KA
TIPDNAPATA
i:
't:
I
:
I
i
I
i
I.
HASBAHHtr
JItrI(.APCTBTHHOTO
IPBIAPATA
HHBAIIHI{
I
vr.hr,:
pac.rBop
Am
auberqnf
lYlyjL]I
I
ms/ml
solution
i*
i,r"",,",
HHBAJIHH
?,5
ur/u;t
pac.r.Bop
o-i,
,r"l_urO
]J
Jy.{lll
2,5
nrg/rnt
rotution
i*
irL"",i*
HIIBAJIHH
5
l.rr
/ua
pacrBop
rns
urrt
erur.rfi
IJy.lLlN
5
nrginr
I
soturic,n
hri
iiu..i,",
-
HHBAIIHH
I0
:vrr/n.rr
pac.r.Bop
A,r:r
nur,erulrE
NIVAI-,IN
l
0
rlg/ml
solurion
i",l
i,ii_"ii",
2,
KATIECTBEHHbIR}IKONHITECTBEHHhIIICOCTAB
ffi{ol,:ffi,.1l,,',,,Jilrrilil3;ffi-fli,,,';,'rTffi,::*.jil.r
ra^rHBl{oe
Beil,ecr,o
ra,a}rraM,Ha
flo.nlrsrfi
nepgqeHb
Bcr.roMorar.eJrorr,,
u*,r,*rrB
fipHBeAer1
r
nygrr.e
6.
L
3.
JIBKAPCTI}trHTIA.,IOOPMA
HurercquoHnufi
pacreop
IfftrTffi#op
'qn,I
nirterqrii
npe/xc'raBrre:'co60fi
npo3paqxyrc
)KlrAr(trc1.b,
or
6ecurersor0
ao
6.neruo-
4.
KIIIHI{r{ECKL|E
AAHHbIE
4.1
fforcalarrus
R
trpHMeHeHnro
HeaporQrrlg
;:lfr:Jr#;:ff$f,f,|#ffiuepoHofi
c,creMr,r
(noauparsx),noHerlpH.r.,
pajrlrKyno,eBpur.
rreBpHr..
;Hffi:l;t#Jl,il3t.:.::lv*t:'eru
nepe/rHHx
po)r{KoB
cnH}{Horo
rrorra
(nocre
nonHoN{HerrHra.
-
uepe6panr"r,,
;;;x,lifflfJ,,iili#rr1,r*,!ro3ra,
rercNoro
qepe'panrnoro
napa.ruva);
-
HapyueirHrr
Hep'lto-rur,rrterrHoro
cHHanca
(vrracreua,
;;;;;;",*ert,a,
IHcrpotprar).
A,ecre':rtonorHfl
pr
'r-rtpyprag
-AJIn
ycrperneuur
o(l(reriron
,r.oanorrp,3,pyrorulrx
HepBr.ro-rvrblueriHr,rx
ffixffi
ff:
:
x:ffi
ffiT;
;ilH:lx'ffi
;
urirmiil
H
rr
e,
H
H'(a
u
M
0
q
e
B
.,
ro
n
o
3
br
p,,
cltcl-eMbr
H
r.{oqFloro
fleAep}r(aH1.r,
Morrr^
r'r
!rlrJvvJlur
H'rc("t(l{x
Hap}'lileHH'x
ncpuSeprlecxoii
uepnuofi
rsleg[grgur
*
np!r
orpar]neHr{r
al.rrHxor-rHHepr..r{rrec*HMH
cpercTBar\.r,.
4.2
{o:uponxa
u
clrocoC
flpu]l€Hrluufl
'{o:ap.axa
H
flpoAorlx(H'rc'{b,ocrt'l,leqeHI4,
raJra''raMH.ro[.r
3aBHcrr
o.r
rr)r(ecr].r
cHMlrroruoB
H
I4HAHnnay
R.rtr
u
oii
uyacr.n
t.rrer
bHoclu
naune
HTots
K
re
qeH
H
r.o.
Ilpru
e
xlercfl
nonxoir(n
o.
B
uv.r^pH
r\.r
br
rrre
{
Ho
H
B
rl,\,[prae
r
r
H
e.
I[,"ffi,J",HiJ:
I]::,.,j:::,:T:l::l:1pa
r{cnc,_,rr,3ye
rc,n
a,,t*pa.i.,(oBpei,,eHHoro,eqeLrHs
ffi

                                
                                전체 문서 읽기
                                
                            

다른 언어로 된 문서

환자 정보 전단 환자 정보 전단 러시아어 11-09-2017

이 제품과 관련된 검색 알림